New York, NY – June 1, 2017 – Tiny Piece, which operates the website 6677g.com and the mobile application Baby Pet Vet Doctor, has changed the way the app is presented in the app store and removed the children’s area from its website,” following an inquiry by the Children’s Advertising Review Unit.
CARU, an investigative unit of the advertising industry’s system of self-regulation, monitors advertising directed to children in all media and across all platforms. CARU also monitors websites and online services for compliance with CARU’s Self-Regulatory Program for Children’s Advertising, which include guidelines on privacy protection, and the federal Children’s Online Privacy Protection Act (COPPA). CARU is administered by the Council of Better Business Bureaus.
Once registered, a visitor could go to her profile page and set her account to public or private. A profile included the user’s gender, birthdate and email address.
“Baby Pet Vet Doctor” is an animated easy to play game that features baby animals. The mobile app was located in the general games category of the Apple App Store, but described as a kid’s game rated 4+. In the Google Play Store, the App was rated T for Teen but described as “the perfect game for children.”
During its initial review, CARU determined that pop-up advertisements for other apps created by the operator would appear throughout “Baby Pet Vet Doctor,” including ads for T-rated games that had inappropriate or disturbing subject matter such as, “Pregnant Mommy’s Surgery,” “My Ex-Boyfriend Comes Back” and “Plastic Surgery Simulator.”
Further, CARU was concerned that the app was rated and described inconsistently on app store platforms and that it appeared to be directed to children. Tiny Piece submitted evidence to support its position that its demographics for the game were adult women.
In response to CARU’s concerns, the company said the site would no longer collect children’s email addresses and that it would delete all the email addresses already collected from children.
CARU noted in its decision that it was pleased the operator “agreed to work with CARU to bring its online services into compliance with CARU’s Guidelines and COPPA.”
NAD Finds Certain Madame Ovary Dietary Supplement Claims Supported
New York, NY – September 24, 2020 – NAD determined that Goop, Inc. supported qualified claims relating to the ability of certain ingredients in its Madame Ovary dietary supplement to provide nutritional support for physical and emotional symptoms of women who are approaching, in, or just past menopause, but recommended modifications to a claim...